180 related articles for article (PubMed ID: 32797679)
1. Daratumumab interference in flow cytometric anti-granulocyte antibody testing can be overcome using non-human blocking antibodies.
Baig NA; Dukek BA; Falbo DK; Wakefield LL; DiGuardo MA; Bobr A; Kreuter JD; Gandhi MJ
Vox Sang; 2021 Jan; 116(1):116-122. PubMed ID: 32797679
[TBL] [Abstract][Full Text] [Related]
2. Resolving the daratumumab interference with blood compatibility testing.
Chapuy CI; Nicholson RT; Aguad MD; Chapuy B; Laubach JP; Richardson PG; Doshi P; Kaufman RM
Transfusion; 2015 Jun; 55(6 Pt 2):1545-54. PubMed ID: 25764134
[TBL] [Abstract][Full Text] [Related]
3. A blockage monoclonal antibody protocol as an alternative strategy to avoid anti-CD38 interference in immunohematological testing.
Chinoca Ziza KN; Paiva TA; Mota SR; Dezan MR; Schmidt LC; Brunetta DM; Ricci G; Basques FV; Barroso-Duarte F; Rocha V; Mendrone-Junior A; Dinardo CL
Transfusion; 2019 May; 59(5):1827-1835. PubMed ID: 30779172
[TBL] [Abstract][Full Text] [Related]
4. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test.
Nguyen XD; Flesch B; Sachs UJ; Kroll H; Klüter H; Müller-Steinhardt M
Transfusion; 2009 Dec; 49(12):2700-8. PubMed ID: 19659676
[TBL] [Abstract][Full Text] [Related]
5. Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method).
Hosokawa M; Kashiwagi H; Nakayama K; Sakuragi M; Nakao M; Morikawa T; Kiyokawa T; Aochi H; Nagamine K; Shibayama H; Tomiyama Y
Transfusion; 2018 Dec; 58(12):3003-3013. PubMed ID: 30267414
[TBL] [Abstract][Full Text] [Related]
6. Use of an in-house trypsin-based method to resolve the interference of daratumumab.
Ibeh N; Baine I; Rudon LF; Lomas-Francis C; Jhang JS; Galdon P; Westhoff CM; Velliquette RW; Arinsburg SA
Transfusion; 2021 Oct; 61(10):3000-3007. PubMed ID: 34472116
[TBL] [Abstract][Full Text] [Related]
7. Detection of granulocyte-reactive antibodies: a comparison of different methods.
Heinzl MW; Schönbacher M; Dauber EM; Panzer S; Mayr WR; Körmöczi GF
Vox Sang; 2015 Apr; 108(3):287-93. PubMed ID: 25556963
[TBL] [Abstract][Full Text] [Related]
8. A novel tool for high-throughput screening of granulocyte-specific antibodies using the automated flow cytometric granulocyte immunofluorescence test (Flow-GIFT).
Nguyen XD; Dengler T; Schulz-Linkholt M; Klüter H
ScientificWorldJournal; 2011 Feb; 11():302-9. PubMed ID: 21298221
[TBL] [Abstract][Full Text] [Related]
9. Efficient neutralization of daratumumab in pretransfusion samples using a novel recombinant monoclonal anti-idiotype antibody.
Aung F; Spencer J; Potter D; Pham TD; Farooqui N; Platt KR; Zayat R; Oliveira M; Smeland-Wagman R; Petersen E; Kaufman RM
Transfusion; 2022 Aug; 62(8):1511-1518. PubMed ID: 35866570
[TBL] [Abstract][Full Text] [Related]
10. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing.
Chapuy CI; Aguad MD; Nicholson RT; AuBuchon JP; Cohn CS; Delaney M; Fung MK; Unger M; Doshi P; Murphy MF; Dumont LJ; Kaufman RM;
Transfusion; 2016 Dec; 56(12):2964-2972. PubMed ID: 27600566
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab Interference in Pretransfusion Testing Is Overcome by Addition of Daratumumab Fab Fragments to Patients' Plasma.
Werle E; Ziebart J; Wasmund E; Eske-Pogodda K
Transfus Med Hemother; 2019 Dec; 46(6):423-430. PubMed ID: 31933572
[TBL] [Abstract][Full Text] [Related]
12. Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma.
Rabut É; Castro-Fernandez A; Le Gall V; Meknache N
Ann Biol Clin (Paris); 2017 Jun; 75(3):351-355. PubMed ID: 28540859
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma.
Cho N; Ko S; Shokeen M
Mol Imaging Biol; 2021 Apr; 23(2):186-195. PubMed ID: 32964391
[TBL] [Abstract][Full Text] [Related]
14. Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab.
Ye Z; Wolf LA; Mettman D; Plapp FV
Vox Sang; 2020 Feb; 115(2):207-212. PubMed ID: 31729042
[TBL] [Abstract][Full Text] [Related]
15. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay.
Rosenberg AS; Bainbridge S; Pahwa R; Jialal I
Clin Biochem; 2016 Oct; 49(15):1202-1204. PubMed ID: 27475249
[TBL] [Abstract][Full Text] [Related]
16. The impact of Daratumumab on transfusion service costs.
Cushing MM; DeSimone RA; Goel R; Hsu YS; Parra P; Racine-Brzostek SE; Degtyaryova D; Lo DT; Morrison M; Crowley KM; Rossi A; Vasovic LV
Transfusion; 2019 Apr; 59(4):1252-1258. PubMed ID: 30620407
[TBL] [Abstract][Full Text] [Related]
17. 2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests.
Zhou Y; Chen L; Jiang T; Fan L; Lei H; Wang Y; Heililahong H; Mi J; Du D; Miao T; Xia R; Wang X; Xiang D; Cai X; Tang X
Hematology; 2021 Dec; 26(1):365-370. PubMed ID: 33971806
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.
Chami B; Okuda M; Moayeri M; Pirenne F; Hidaka Y; Nambiar A; Song Z; Bedel O; Zhang B; Hopke J; Deng G; Zhu C; Macé S; Chiron M; Adrian F; Fukao T; Basile FG; Martin T
Transfusion; 2022 Nov; 62(11):2334-2348. PubMed ID: 36239134
[TBL] [Abstract][Full Text] [Related]
19. Effect of clinical application of anti-CD38 and anti-CD47 monoclonal antibodies on blood group detection and transfusion therapy and treatment.
Du C; Sui W; Huang H; Zhang Y; Ding X; Gao C; Wang Y
Leuk Res; 2022 Nov; 122():106953. PubMed ID: 36182722
[TBL] [Abstract][Full Text] [Related]
20. Artifactual Kappa Light Chain Restriction of Marrow Hematogones: A Potential Diagnostic Pitfall in Minimal Residual Disease Assessment of Plasma Cell Myeloma Patients on Daratumumab.
Jiang XY; Luider J; Shameli A
Cytometry B Clin Cytom; 2020 Jan; 98(1):68-74. PubMed ID: 31313879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
